Investors

Overview

OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. We are developing molecular information products and services for global healthcare settings, helping to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs.

Shareholder Tools

Latest News
09.15.21
OpGen Announces Data from Prospective Randomized Controlled Multicenter Clinical Study Using the Unyvero HPN Panel for Hospitalized Patients with Suspicion of Pneumonia
08.12.21
OpGen Reports Second Quarter 2021 Financial Results and Provides Business Update
08.04.21
OpGen Announces the Cancellation of Adjourned Portion of Annual Meeting

btn News

See All News

Upcoming Events
More events are coming soon.

btn Events

See all events